Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-20-029869
Filing Date
2020-12-30
Accepted
2020-12-30 13:14:58
Documents
1
Period of Report
2020-12-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3572
  Complete submission text file 0001140361-20-029869.txt   4909
Mailing Address C/O CYCLERION THERAPEUTICS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Currie Mark G (Reporting) CIK: 0001478244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38787 | Film No.: 201425132

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Issuer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations